Maternal serum levels of interleukin-6 and clinical characteristics of normal delivery at term

被引:32
作者
Arntzen, KJ
Lien, E
Austgulen, R
机构
[1] Institute of Cancer Research and Molecular Biology, University Medical Center, Trondheim
关键词
interleukin-6; soluble tumor necrosis factor receptor; term labor; tumor necrosis factor;
D O I
10.3109/00016349709047785
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. The objective of the present study was to study participation of cytokines and cytokine inhibitors during the process of normal parturition, as assessed by maternal serum levels of interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor (TNF) and soluble tumor necrosis factor receptors (sTNFRs, p55 and p75). Materials and methods. Twenty-six healthy women in normal term labor were observed during parturition and until 2 h post partum. Serum was sampled every 2 h, and an evaluation of strength and frequency of contractions was performed at the time of sampling. Concentrations of IL-1, IL-6, TNF, p55 and p75 were analyzed, and non-parametric tests were used to study whether any relationship existed between the serum analyzes and the clinical characteristics of parturition. Results. There was a significant association between the strength of contractions and the levels of IL-6 and p55. In addition, IL-6 concentrations and frequency of contractions were correlated. Maternal serum levels of IL-6 and p55 were highest 2 h post partum. TNF activity was detected in samples from nine women, whereas IL-1 was not found in any sample. Conclusions. The present study suggests a role of IL-6 and p55 in normal labor. However, as women being studied already were in labor, the study does not allow any conclusions whether observed changes in IL-6 and p55 levels have a causal relation to the process of labor or if changes are secondary effects of the process itself.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 31 条
[1]   PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES [J].
AARDEN, LA ;
DEGROOT, ER ;
SCHAAP, OL ;
LANSDORP, PM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1411-1416
[2]   SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR IN SERUM AND URINE THROUGHOUT NORMAL-PREGNANCY AND AT DELIVERY [J].
ARNTZEN, KJ ;
LIABAKK, NB ;
JACOBSEN, G ;
ESPEVIK, T ;
AUSTGULEN, R .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1995, 34 (03) :163-169
[3]   EXPRESSION OF RECEPTORS FOR TUMOR-NECROSIS-FACTOR IN HUMAN PLACENTA AT TERM [J].
AUSTGULEN, R ;
ESPEVIK, T ;
MECSEI, R ;
SCOTT, H .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 (06) :417-424
[4]   INCREASED LEVELS OF CYTOKINES AND CYTOKINE ACTIVITY MODIFIERS IN NORMAL-PREGNANCY [J].
AUSTGULEN, R ;
LIEN, E ;
LIABAKK, NB ;
JACOBSEN, G ;
ARNTZEN, KJ .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1994, 57 (03) :149-155
[5]  
BAERGEN R, 1994, ARCH PATHOL LAB MED, V118, P52
[6]   EVIDENCE OF PARTICIPATION OF THE SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-I IN THE HOST RESPONSE TO INTRAUTERINE INFECTION IN PRETERM LABOR [J].
BAUMANN, P ;
ROMERO, R ;
BERRY, S ;
GOMEZ, R ;
MCFARLIN, B ;
ARANEDA, H ;
COTTON, DB ;
FIDEL, P .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1993, 30 (2-3) :184-193
[7]  
BEMELMANS MHA, 1993, J IMMUNOL, V151, P5554
[8]  
BENRAFAEL Z, 1992, FERTIL STERIL, V58, P1093
[9]  
CLARK DA, 1991, ANN NY ACAD SCI, V626, P524
[10]  
DEMBIC Z, 1990, Cytokine, V2, P231, DOI 10.1016/1043-4666(90)90022-L